Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash to Debt No Debt
MSON's Cash to Debt is ranked higher than
99% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. MSON: No Debt )
Ranked among companies with meaningful Cash to Debt only.
MSON' s 10-Year Cash to Debt Range
Min: 0.13  Med: 2.86 Max: No Debt
Current: No Debt
Equity to Asset 0.89
MSON's Equity to Asset is ranked higher than
94% of the 280 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. MSON: 0.89 )
Ranked among companies with meaningful Equity to Asset only.
MSON' s 10-Year Equity to Asset Range
Min: 0.5  Med: 0.73 Max: 0.89
Current: 0.89
0.5
0.89
Interest Coverage No Debt
MSON's Interest Coverage is ranked higher than
98% of the 167 Companies
in the Global Medical Devices industry.

( Industry Median: 10000.00 vs. MSON: No Debt )
Ranked among companies with meaningful Interest Coverage only.
MSON' s 10-Year Interest Coverage Range
Min: 2.41  Med: 19.18 Max: 9999.99
Current: No Debt
2.41
9999.99
F-Score: 7
Z-Score: 19.33
M-Score: -3.22
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating margin (%) -6.84
MSON's Operating margin (%) is ranked lower than
62% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. MSON: -6.84 )
Ranked among companies with meaningful Operating margin (%) only.
MSON' s 10-Year Operating margin (%) Range
Min: -35.87  Med: -4.22 Max: 23.51
Current: -6.84
-35.87
23.51
Net-margin (%) 14.87
MSON's Net-margin (%) is ranked higher than
86% of the 302 Companies
in the Global Medical Devices industry.

( Industry Median: 1.99 vs. MSON: 14.87 )
Ranked among companies with meaningful Net-margin (%) only.
MSON' s 10-Year Net-margin (%) Range
Min: -28.56  Med: 2.02 Max: 19.78
Current: 14.87
-28.56
19.78
ROE (%) 18.25
MSON's ROE (%) is ranked higher than
86% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. MSON: 18.25 )
Ranked among companies with meaningful ROE (%) only.
MSON' s 10-Year ROE (%) Range
Min: -21.42  Med: 2.36 Max: 31.93
Current: 18.25
-21.42
31.93
ROA (%) 15.80
MSON's ROA (%) is ranked higher than
95% of the 320 Companies
in the Global Medical Devices industry.

( Industry Median: -0.33 vs. MSON: 15.80 )
Ranked among companies with meaningful ROA (%) only.
MSON' s 10-Year ROA (%) Range
Min: -18.21  Med: 1.81 Max: 24.04
Current: 15.8
-18.21
24.04
ROC (Joel Greenblatt) (%) 32.12
MSON's ROC (Joel Greenblatt) (%) is ranked higher than
79% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. MSON: 32.12 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MSON' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -64.12  Med: -7.82 Max: 59.76
Current: 32.12
-64.12
59.76
Revenue Growth (3Y)(%) 8.80
MSON's Revenue Growth (3Y)(%) is ranked higher than
70% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 3.00 vs. MSON: 8.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MSON' s 10-Year Revenue Growth (3Y)(%) Range
Min: -35.2  Med: 4.80 Max: 36.3
Current: 8.8
-35.2
36.3
» MSON's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

MSON Guru Trades in Q2 2014

Jim Simons 116,100 sh (+1.49%)
» More
Q3 2014

MSON Guru Trades in Q3 2014

Jim Simons 120,300 sh (+3.62%)
» More
Q4 2014

MSON Guru Trades in Q4 2014

Jim Simons 138,100 sh (+14.80%)
» More
Q1 2015

MSON Guru Trades in Q1 2015

Jim Simons 134,000 sh (-2.97%)
» More
» Details

Insider Trades

Latest Guru Trades with MSON

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 24.40
MSON's P/E(ttm) is ranked higher than
60% of the 156 Companies
in the Global Medical Devices industry.

( Industry Median: 29.20 vs. MSON: 24.40 )
Ranked among companies with meaningful P/E(ttm) only.
MSON' s 10-Year P/E(ttm) Range
Min: 5.18  Med: 32.27 Max: 303
Current: 24.4
5.18
303
PE(NRI) 26.40
MSON's PE(NRI) is ranked higher than
56% of the 154 Companies
in the Global Medical Devices industry.

( Industry Median: 29.20 vs. MSON: 26.40 )
Ranked among companies with meaningful PE(NRI) only.
MSON' s 10-Year PE(NRI) Range
Min: 19.77  Med: 35.91 Max: 200
Current: 26.4
19.77
200
P/B 3.67
MSON's P/B is ranked lower than
58% of the 288 Companies
in the Global Medical Devices industry.

( Industry Median: 3.18 vs. MSON: 3.67 )
Ranked among companies with meaningful P/B only.
MSON' s 10-Year P/B Range
Min: 0.26  Med: 1.45 Max: 5.83
Current: 3.67
0.26
5.83
P/S 3.56
MSON's P/S is ranked lower than
55% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. MSON: 3.56 )
Ranked among companies with meaningful P/S only.
MSON' s 10-Year P/S Range
Min: 0.12  Med: 1.08 Max: 5.71
Current: 3.56
0.12
5.71
PFCF 28.91
MSON's PFCF is ranked higher than
57% of the 115 Companies
in the Global Medical Devices industry.

( Industry Median: 31.27 vs. MSON: 28.91 )
Ranked among companies with meaningful PFCF only.
MSON' s 10-Year PFCF Range
Min: 23.68  Med: 42.19 Max: 462
Current: 28.91
23.68
462
POCF 25.00
MSON's POCF is ranked lower than
55% of the 149 Companies
in the Global Medical Devices industry.

( Industry Median: 22.43 vs. MSON: 25.00 )
Ranked among companies with meaningful POCF only.
MSON' s 10-Year POCF Range
Min: 19.71  Med: 37.61 Max: 278
Current: 25
19.71
278
EV-to-EBIT 27.36
MSON's EV-to-EBIT is ranked lower than
60% of the 162 Companies
in the Global Medical Devices industry.

( Industry Median: 22.74 vs. MSON: 27.36 )
Ranked among companies with meaningful EV-to-EBIT only.
MSON' s 10-Year EV-to-EBIT Range
Min: -82.3  Med: -5.90 Max: 116.6
Current: 27.36
-82.3
116.6
Current Ratio 7.19
MSON's Current Ratio is ranked higher than
85% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. MSON: 7.19 )
Ranked among companies with meaningful Current Ratio only.
MSON' s 10-Year Current Ratio Range
Min: 1.55  Med: 3.53 Max: 9.22
Current: 7.19
1.55
9.22
Quick Ratio 5.44
MSON's Quick Ratio is ranked higher than
82% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 2.02 vs. MSON: 5.44 )
Ranked among companies with meaningful Quick Ratio only.
MSON' s 10-Year Quick Ratio Range
Min: 0.76  Med: 2.32 Max: 7.5
Current: 5.44
0.76
7.5
Days Inventory 223.58
MSON's Days Inventory is ranked lower than
74% of the 280 Companies
in the Global Medical Devices industry.

( Industry Median: 130.93 vs. MSON: 223.58 )
Ranked among companies with meaningful Days Inventory only.
MSON' s 10-Year Days Inventory Range
Min: 81.28  Med: 154.17 Max: 397.65
Current: 223.58
81.28
397.65
Days Sales Outstanding 61.05
MSON's Days Sales Outstanding is ranked higher than
62% of the 274 Companies
in the Global Medical Devices industry.

( Industry Median: 68.45 vs. MSON: 61.05 )
Ranked among companies with meaningful Days Sales Outstanding only.
MSON' s 10-Year Days Sales Outstanding Range
Min: 55.99  Med: 75.26 Max: 111.68
Current: 61.05
55.99
111.68

Valuation & Return

vs
industry
vs
history
Price/Net Cash 11.01
MSON's Price/Net Cash is ranked higher than
59% of the 96 Companies
in the Global Medical Devices industry.

( Industry Median: 14.32 vs. MSON: 11.01 )
Ranked among companies with meaningful Price/Net Cash only.
MSON' s 10-Year Price/Net Cash Range
Min: 1.88  Med: 12.31 Max: 86.82
Current: 11.01
1.88
86.82
Price/Net Current Asset Value 4.84
MSON's Price/Net Current Asset Value is ranked higher than
60% of the 190 Companies
in the Global Medical Devices industry.

( Industry Median: 6.26 vs. MSON: 4.84 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
MSON' s 10-Year Price/Net Current Asset Value Range
Min: 0.72  Med: 3.04 Max: 8.6
Current: 4.84
0.72
8.6
Price/Tangible Book 4.30
MSON's Price/Tangible Book is ranked higher than
51% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. MSON: 4.30 )
Ranked among companies with meaningful Price/Tangible Book only.
MSON' s 10-Year Price/Tangible Book Range
Min: 0.43  Med: 2.04 Max: 8.04
Current: 4.3
0.43
8.04
Price/Projected FCF 25.69
MSON's Price/Projected FCF is ranked lower than
95% of the 101 Companies
in the Global Medical Devices industry.

( Industry Median: 2.13 vs. MSON: 25.69 )
Ranked among companies with meaningful Price/Projected FCF only.
MSON' s 10-Year Price/Projected FCF Range
Min: 0.66  Med: 2.23 Max: 137.44
Current: 25.69
0.66
137.44
Price/Median PS Value 3.29
MSON's Price/Median PS Value is ranked lower than
94% of the 243 Companies
in the Global Medical Devices industry.

( Industry Median: 1.11 vs. MSON: 3.29 )
Ranked among companies with meaningful Price/Median PS Value only.
MSON' s 10-Year Price/Median PS Value Range
Min: 0.13  Med: 1.14 Max: 4.85
Current: 3.29
0.13
4.85
Price/Graham Number 2.18
MSON's Price/Graham Number is ranked higher than
53% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 2.37 vs. MSON: 2.18 )
Ranked among companies with meaningful Price/Graham Number only.
MSON' s 10-Year Price/Graham Number Range
Min: 0.47  Med: 1.40 Max: 8.33
Current: 2.18
0.47
8.33
Earnings Yield (Greenblatt) (%) 3.70
MSON's Earnings Yield (Greenblatt) (%) is ranked higher than
70% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.80 vs. MSON: 3.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MSON' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 0.9  Med: 2.85 Max: 5.9
Current: 3.7
0.9
5.9

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:MX9.Germany,
Misonix Inc a New York corporation organized in 1959. The Company designs, manufactures, markets and develops minimally invasive ultrasonic medical device products. These products include the BoneScalpel cutting system which is used among other things for surgical procedures of the spine and on Maxillofacial procedures, the SonaStar Surgical Aspirator which is used to emulsify and remove soft and hard tumors, the SonicOne Wound Cleansing and Debridement System which offers tissue specific debridement and cleansing of wounds for effective removal of devitalized tissue and fibrin deposits while sparing viable cells and the AutoSonix ultrasound cutting and coagulating system which is distributed and marketed for Misonix through Mentor Corporation, a subsidiary of Johnson & Johnson. The Company applications include the ability to transect or shape bone, ablate and aspirate both soft and hard tissue, cleanse and debride advanced wounds and remove unwanted body fat. Among clinical specialties served are: Spine Surgery, Skull-Based Surgery (i.e., Cranio-Maxillo-Facial, Neurosurgery, Orthopedic Surgery and Plastic surgery). The Company sells its SonicOne Wound Cleansing and Debridement System, through direct sales persons and sales agents or distributors worldwide. The Companys main competitors are Johnson & Johnson, Valley Lab, a division of Tyco Healthcare, Integra Life Sciences, Inc., Sööring, and Stryker. The Companys medical device products are subject to the regulatory requirements of the U.S. Food and Drug Administration.
» More Articles for MSON

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight May 19 2013 
comment on MSON Mar 06 2013 
MISONIX Inc. (MSON) CEO Michael A Jr Mcmanus buys 5,000 Shares Dec 01 2009 
MISONIX Inc. Reports Operating Results (10-Q) Nov 16 2009 
MISONIX Inc. Reports Operating Results (10-K) Sep 28 2009 
FirstEnergy Files Application To Consolidate Transmission Assets Into PJM Aug 17 2009 
Misonix Announces the Sale of Its Labcaire Business for up to $5.6 Million Aug 05 2009 
MISONIX Inc. Reports Operating Results (10-Q) May 12 2009 
Misonix Reports Earnings and Increased Revenues for the Three and Six Months Ended December 31, 2008 Feb 09 2009 
Misonix Announces New HIFU Distribution Agreement for Italy Jan 05 2009 

More From Other Websites
Misonix, Inc. Unveils New SonicOne® O.R. App To Highlight Advantages of Ultrasonic Wound... Jul 23 2015
Misonix, Inc. Unveils New SonicOne® O.R. App To Highlight Advantages of Ultrasonic Wound... Jul 23 2015
BoneScalpel™ Workshop Draws More Than 70 Surgeons At IMAST Meeting Jul 21 2015
BoneScalpel™ Workshop Draws More Than 70 Surgeons At IMAST Meeting Jul 21 2015
Misonix Launches Faster SonicOne® Ultrasonic Debridement Procedure Jul 09 2015
Misonix Launches Faster SonicOne® Ultrasonic Debridement Procedure Jul 09 2015
MISONIX INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Jul 08 2015
Distinguished Surgeons to Conduct Workshop on the Misonix BoneScalpel™ at the International... Jul 07 2015
Distinguished Surgeons to Conduct Workshop on the Misonix BoneScalpel™ at the International... Jul 07 2015
Misonix Announces Presentation at Leading Spine Surgery Conference Promoting the BoneScalpel™ in... Jun 23 2015
Misonix Announces Presentation at Leading Spine Surgery Conference Promoting the BoneScalpel™ in... Jun 23 2015
Edited Transcript of MSON earnings conference call or presentation 7-May-15 8:30pm GMT Jun 17 2015
Misonix Introduces The New 25-Millimeter Blade To The BoneScalpel™ Portfolio Jun 02 2015
Misonix Introduces The New 25-Millimeter Blade To The BoneScalpel™ Portfolio Jun 02 2015
BoneScalpel™ Featured in Leading Spine Publication May 27 2015
BoneScalpel™ Featured in Leading Spine Publication May 27 2015
MISONIX INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and... May 26 2015
MISONIX INC Financials May 19 2015
MISONIX INC Files SEC form 8-K, Change in Directors or Principal Officers May 13 2015
10-Q for Misonix, Inc. May 09 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK